Bikui Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bikui Tang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jun Xi
College of Life Science, Bengbu Medical University, Bengbu, China
4 shared publications Kaiqiang Qian
College of Life Science, Bengbu Medical University, Bengbu, China
2 shared publicationsMeili Wei
School of Life Science, Bengbu Medical College, Bengbu 233030, PR China
2 shared publicationsShengwen Shang
School of Life Science, Bengbu Medical College, Bengbu 233030, PR China
2 shared publicationsTianyue Li
School of Life Science, Bengbu Medical College, Bengbu 233030, PR China
2 shared publicationsLidong Shan
School of Life Science, Bengbu Medical College, Bengbu 233030, PR China
1 shared publication
Latest Publications
- 12 December 2025
- Published by Springer Nature in Current Microbiology
- Vol. 83 (1) , 78
Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection
Mycobacterium tuberculosis (Mtb), a highly infectious intracellular pathogen, is the primary causative agent of tuberculosis (TB), which ranks as the leading cause of death from individual infectious agents. In this context, we developed a model using macrophages infected with M. smegmatis mc2155 and Mtb H37Ra to elucidate the role of Mn2+ in host defense against tuberculosis infection. Treatment with a combination of anti-tuberculosis drugs and Mn2+ for 36 h markedly reduced the survival of intracellular bacteria, and the addition of Mn2+ significantly enhanced the secretion of TNF-α and IL-1β. In mice infected with Mtb H37Ra, treatment with Mn2+ (2 mg/kg) and the combination of Isoniazid and Mn2+ significantly increased serum TNF-α levels, with the combination treatment showing a more pronounced effect. Histopathological analysis indicated a relatively diminished immune response in the spleen in the drug and Mn2+treatment groups, while the immune response in the lungs was comparable across all groups. Mn2+ can synergistically enhance the efficacy of anti-tuberculosis drugs by activating cellular secretion of immune factors and inhibiting the growth of Mtb. The findings of this study provide a rationale for the potential use of Mn2+ as an activator of cellular immunity against Mtb infection.
- 12 December 2025
- Published by Springer Nature in Current Microbiology
- Vol. 83 (1) , 78
Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection
Mycobacterium tuberculosis (Mtb), a highly infectious intracellular pathogen, is the primary causative agent of tuberculosis (TB), which ranks as the leading cause of death from individual infectious agents. In this context, we developed a model using macrophages infected with M. smegmatis mc2155 and Mtb H37Ra to elucidate the role of Mn2+ in host defense against tuberculosis infection. Treatment with a combination of anti-tuberculosis drugs and Mn2+ for 36 h markedly reduced the survival of intracellular bacteria, and the addition of Mn2+ significantly enhanced the secretion of TNF-α and IL-1β. In mice infected with Mtb H37Ra, treatment with Mn2+ (2 mg/kg) and the combination of Isoniazid and Mn2+ significantly increased serum TNF-α levels, with the combination treatment showing a more pronounced effect. Histopathological analysis indicated a relatively diminished immune response in the spleen in the drug and Mn2+treatment groups, while the immune response in the lungs was comparable across all groups. Mn2+ can synergistically enhance the efficacy of anti-tuberculosis drugs by activating cellular secretion of immune factors and inhibiting the growth of Mtb. The findings of this study provide a rationale for the potential use of Mn2+ as an activator of cellular immunity against Mtb infection.
- 18 March 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (4) , 1-13
Important role of DNA methylation hints at significant potential in tuberculosis
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb) infection, has persisted as a major global public health threat for millennia. Until now, TB continues to challenge efforts aimed at controlling it, with drug resistance and latent infections being the two main factors hindering treatment efficacy. The scientific community is still striving to understand the underlying mechanisms behind Mtb’s drug resistance and latent infection. DNA methylation, a critical epigenetic modification occurring throughout an individual's growth and development, has gained attention following advances in high-throughput sequencing technologies. Researchers have observed abnormal DNA methylation patterns in the host genome during Mtb infection. Given the escalating issue of drug-resistant Mtb, delving into the role of DNA methylation in TB's development is crucial. This review article explores DNA methylation's significance in human growth, development and disease, and its role in regulating Mtb’s evolution and infection processes. Additionally, it discusses potential applications of DNA methylation research in tuberculosis.
- 18 March 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (4) , 1-13
Important role of DNA methylation hints at significant potential in tuberculosis
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb) infection, has persisted as a major global public health threat for millennia. Until now, TB continues to challenge efforts aimed at controlling it, with drug resistance and latent infections being the two main factors hindering treatment efficacy. The scientific community is still striving to understand the underlying mechanisms behind Mtb’s drug resistance and latent infection. DNA methylation, a critical epigenetic modification occurring throughout an individual's growth and development, has gained attention following advances in high-throughput sequencing technologies. Researchers have observed abnormal DNA methylation patterns in the host genome during Mtb infection. Given the escalating issue of drug-resistant Mtb, delving into the role of DNA methylation in TB's development is crucial. This review article explores DNA methylation's significance in human growth, development and disease, and its role in regulating Mtb’s evolution and infection processes. Additionally, it discusses potential applications of DNA methylation research in tuberculosis.
- 23 November 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt B) , 109471
Manganese enhances macrophage defense against Mycobacterium tuberculosis via the STING-TNF signaling pathway
- 23 November 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt B) , 109471
Manganese enhances macrophage defense against Mycobacterium tuberculosis via the STING-TNF signaling pathway
- 1 September 2022
- Published by The Microbiological Society of Korea in Journal of Microbiology
- Vol. 60 (11) , 1095-1105
Sulforaphane kills Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis mc2155 through a reactive oxygen species dependent mechanism
Mycobacterium tuberculosis (M. tuberculosis) is a highly pathogenic intracellular pathogen that causes tuberculosis (TB), the leading cause of mortality from single infections. Redox homeostasis plays a very important role in the resistance of M. tuberculosis to antibiotic damage and various environmental stresses. The antioxidant sulforaphane (SFN) has been reported to exhibit anticancer activity and inhibit the growth of a variety of bacteria and fungi. Nonetheless, it remains unclear whether SFN exhibits anti-mycobacterial activity. Our results showed that the SFN against M. tuberculosis H37Ra exhibited bactericidal activity in a time and dose-dependent manner. The anti-tubercular activity of SFN was significantly correlated with bacterial reactive oxygen species (ROS) levels. In addition, SFN promoted the bactericidal effect of macrophages on intracellular bacteria in a dose-dependent manner, mediated by increasing intracellular mitochondrial ROS levels and decreasing cytoplasmic ROS levels. Taken together, our data revealed the previously unrecognized antimicrobial functions of SFN. Future studies focusing on the mechanism of SFN in macrophages against M. tuberculosis are essential for developing new host-directed therapeutic approaches against TB.
- 1 September 2022
- Published by The Microbiological Society of Korea in Journal of Microbiology
- Vol. 60 (11) , 1095-1105
Sulforaphane kills Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis mc2155 through a reactive oxygen species dependent mechanism
Mycobacterium tuberculosis (M. tuberculosis) is a highly pathogenic intracellular pathogen that causes tuberculosis (TB), the leading cause of mortality from single infections. Redox homeostasis plays a very important role in the resistance of M. tuberculosis to antibiotic damage and various environmental stresses. The antioxidant sulforaphane (SFN) has been reported to exhibit anticancer activity and inhibit the growth of a variety of bacteria and fungi. Nonetheless, it remains unclear whether SFN exhibits anti-mycobacterial activity. Our results showed that the SFN against M. tuberculosis H37Ra exhibited bactericidal activity in a time and dose-dependent manner. The anti-tubercular activity of SFN was significantly correlated with bacterial reactive oxygen species (ROS) levels. In addition, SFN promoted the bactericidal effect of macrophages on intracellular bacteria in a dose-dependent manner, mediated by increasing intracellular mitochondrial ROS levels and decreasing cytoplasmic ROS levels. Taken together, our data revealed the previously unrecognized antimicrobial functions of SFN. Future studies focusing on the mechanism of SFN in macrophages against M. tuberculosis are essential for developing new host-directed therapeutic approaches against TB.